People In Brief
This article was originally published in The Gray Sheet
Executive Summary
Biomet Orthopedics: Jon Serbousek signs on as president of Biomet's joint reconstruction products unit March 3. Serbousek was most recently VP of biologics at Medtronic and prior to that held management positions at the device giant in spinal reconstruction among other areas. He has also served in a variety of executive positions at DePuy
You may also be interested in...
People In Brief
Device lobby hire: Elizabeth Pika moves from her post as legislative director for Rep. Tammy Baldwin, D-Wis., to become VP-government affairs at AdvaMed. Pika, replacing Seth Radus who left in May to join AdvaMed member firm Siemens, will play a particularly active role in advocating for the reform of how Medicare reimburses for molecular diagnostics in the model of the pending "Medicare Advanced Laboratory Diagnostics Act" (1"The Gray Sheet" Dec. 10, 2007, p. 13). Pika will report to Brett Loper, who joined AdvaMed in May to work with David Nexon in running the association's lobbying efforts (2"The Gray Sheet" May 5, 2008, p. 6)
How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack O’Meara, about its human tissue-based drug discovery platform, its resulting RNA platform for liver disease and how the fledgling drug company's early work mirrored that seen in diagnostics.